The goal of this project is to provide an evidence-based online curriculum for health care providers and trainers of health care providers to increase their knowledge on human immunodeficiency virus (...
Comprehensive guidelines, including:
This training slide set covers aging-related concerns for people with HIV, including management of ART. Nearly half of people with HIV in the United States are aged over 50. Topics include epidemiolog...
Three sets of training slides covering what providers treating people with HIV should know about COVID-19. Overall learning objectives include identifying risk factors for and strategies to reduce sev...
Hepatitis C Online is a free educational website from the University of Washington National Hepatitis Training Center. This project is funded by the Centers for Disease Control and Prevention (CDC).
Th...
Archived webinar.
Dr. Adrienne E Shapiro discusses highlights from the 2021 IAS Conference.
Training slides review potential ARV drug-drug interactions and identify resources for the evaluation of drug-drug interactions.
The National HIV Curriculum (NHC) provides free, up-to-date content for clinicians to learn about HIV diagnosis, treatment, and prevention. The 37 lessons and corresponding question bank topics offer...
Each year HRSA's HIV/AIDS Bureau sponsors a conference for Ryan White Program clinicians to learn about advances in care and treatment. The AETC National Coordinating Resource Center and its partner,...
A collection of clinical guides regarding drug interactions of hepatitis C virus (HCV) direct-acting antivirals (DAAs) with other common primary care medications and HIV antiretrovirals.
This digital glossary of HIV-related terms includes both lay and scientific descriptions and illustrations. Materials are in the public domain and may be used freely. The glossary and images are also...
Recommended management strategies for HIV patients experiencing virologic failure (VF) while taking antiretroviral therapy (ART). The potential causes of VF are complex, and require careful assessment...
Training slides cover HHS recommendations for treatment of transgender people with HIV. Topics include HIV-related epidemiology, barriers to care, gender affirmation, including medical gender affirmat...
Approximately 7/10 people with HIV in the U.S. are not virally suppressed. This infographic illustrates some of the barriers to achieving viral load suppression, and offers suggestions and resources t...
AETC HIV and Aging Workgroup
HIV and Aging Toolkit
Upon watching this video viewers will :
The infographic outlines the purpose and methodology for integrating HIV care into interprofessional education (IPE) and identifies how the AETC Program is helping to facilitate this training through...
Quick guide to oral contraceptives and HIV medications drug interactions.
Co-Author: Susa Coffey, MD; Medical Editor, AETC National Resource Center
An open-label study is evaluating the renal safety of elvitegravir/cobicistat/emtricitabine/tenofovir (Stribild, or the "quad" pill) and cobicistat. For those patients with mild-to-moderate renal impairment (estimated glomerula...
Coauthor: Susa Coffey, MD; Medical Editor, AETC National Resource Center
Treatment of dyslipidemia is often complicated by drug interactions between statins and antiretrovirals. Pitavastatin is one of the newer statins approved and is one of the few that is not metabolized primarily by the CYP450 3A4...
The prevailing opinion among experts regarding the optimal CD4 T-cell count at which to start patients on antiretroviral therapy (ART) has shifted several times during the evolution of HIV treatment. These shifts reflect attempts to strike a balance between preventing HIV-associated illness and deat...
Researchers at the 2016 Conference on Retroviruses and Opportunistic Infections presented results from a randomized double-blind, double-dummy switch study of TAF/FTC. Over 660 patients with virologic suppression on TDF/FTC-containing 3-drug regimens were either switched to TAF/FTC (200/10 mg with b...
Three studies presented at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI) explored the pharmacokinetics of antiretrovirals administered during pregnancy. These studies support the use of standard-dose efavirenz, once-daily dolutegravir, and BID ritonavir-boosted darunavir du...
Treatment of tuberculosis (TB) in HIV-infected persons remains challenging, in part because of drug interactions between rifampin and some ARVs that may compromise antiretroviral therapy (ART). Three studies presented at CROI provide clinicians with additional guidance on how to manage certain inter...
In 2018, initial results from the Tsepamo study of birth outcomes in Botswanan women treated with ART during pregnancy raised questions about the safety of dolutegravir (DTG) when given at the time of conception or very early in pregnancy. Specifically, an early interim analysis found a higher propo...
